These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32727695)

  • 1. [Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange].
    Benhamou Y; Sauvètre G; Grangé S; Veyradier A; Coppo P
    Rev Med Interne; 2020 Dec; 41(12):809-813. PubMed ID: 32727695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura.
    Tse B; Lim G; Sholzberg M; Pavenski K
    J Thromb Haemost; 2020 Nov; 18(11):2870-2877. PubMed ID: 33448602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of thrombotic thrombocytopenic purpura in two French centers: A series of 27 patients].
    Deroux A; Sirodot M; Daguindau N; Barro C; Coppo P; Bouillet L
    Rev Med Interne; 2016 Jan; 37(1):13-8. PubMed ID: 26065327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
    Som S; Deford CC; Kaiser ML; Terrell DR; Kremer Hovinga JA; Lämmle B; George JN; Vesely SK
    Transfusion; 2012 Dec; 52(12):2525-32; quiz 2524. PubMed ID: 22501034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience.
    McGuckin S; Westwood JP; Webster H; Collier D; Leverett D; Scully M
    Vox Sang; 2014 Feb; 106(2):161-6. PubMed ID: 24117855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
    Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
    J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
    Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura.
    Yarranton H; Cohen H; Pavord SR; Benjamin S; Hagger D; Machin SJ
    Br J Haematol; 2003 Jun; 121(5):778-85. PubMed ID: 12780794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
    Garraud O; Malot S; Herbrecht R; Ojeda-Uribe M; Lin JS; Veyradier A; Payrat JM; Liu K; Corash L; Coppo P
    Transfus Apher Sci; 2019 Dec; 58(6):102665. PubMed ID: 31740165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience.
    Tse B; Buchholz M; Pavenski K
    Platelets; 2023 Dec; 34(1):2157807. PubMed ID: 36636834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT).
    Gómez-Seguí I; Francés Aracil E; Mingot-Castellano ME; Vara Pampliega M; Goterris Viciedo R; García Candel F; Pascual Izquierdo C; Del Río Garma J; Guerra Domínguez L; Vicuña Andrés I; Garcia-Arroba Peinado J; Zalba Marcos S; Vidan Estévez JM; González Arias E; Campuzano Saavedra V; García Gala JM; Ortega Sanchez S; Martínez Nieto J; Pardo Gambarte L; Solé Rodríguez M; Fernández-Docampo M; Avila Idrovo LF; Hernández L; Cid J; de la Rubia Comos J;
    Br J Haematol; 2023 Dec; 203(5):860-871. PubMed ID: 37723363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura.
    Colling M; Sun L; Upadhyay V; Ryu J; Li A; Uhl L; Kaufman RM; Stowell CP; Dzik WH; Makar RS; Bendapudi PK
    Transfusion; 2020 Apr; 60(4):841-846. PubMed ID: 32080877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP).
    Chen M; Shortt J
    Transfus Med Rev; 2022 Oct; 36(4):204-214. PubMed ID: 36396570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura.
    Picod A; Coppo P
    Expert Rev Hematol; 2019 Jun; 12(6):461-471. PubMed ID: 31092093
    [No Abstract]   [Full Text] [Related]  

  • 15. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.
    Blombery P; Kivivali L; Pepperell D; McQuilten Z; Engelbrecht S; Polizzotto MN; Phillips LE; Wood E; Cohney S;
    Intern Med J; 2016 Jan; 46(1):71-9. PubMed ID: 26477687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
    Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
    Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
    Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
    Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
    Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.